A jury in the US has ruled against Abbott Laboratories in a case concerning premature infant formulas. As a result, the Reckitt (LSE:RKT) share price is down 8%.
The FTSE 100 company has a similar problem of its own. But with the stock now 33% lower than it was five years ago, could this be the time to buy the stock ahead of a potential recovery?
Infant formula
Reckitt paid $17bn to acquire infant formula subsidiary Mead Johnson in 2017. And the division has been nothing but trouble for the FTSE 100 company since.
The business is now trying to dispose of the unit, but it’s unlikely to get anything like that back. Aside from the fact it overpaid for the deal in the first place, there’s now a big legal issue.
In March, a US court ruled in favour of a mother whose premature baby died after consuming a Reckitt product. That cost the firm $60m, but the question now is whether there’s more to come.
The latest ruling against Abbott Labs suggests there might be. And this means the company is likely to get even less for the baby milk subsidiary it’s trying to sell.
The bigger picture
Selling off the infant formula division is only one part of a broader restructuring plan for Reckitt. The company has a broad portfolio of brands, some of which are stronger than others.
The trouble with this is the weaker divisions weigh on the growth of the firm as a whole. So the plan is to focus on the strongest lines, divest the others, and use the cash for share buybacks.
Unilever has been working on a similar plan since the start of the year. I think this has been a success so far and I can see how there might be a similar opportunity for Reckitt.
If the company can execute this plan successfully, shareholders could be in a good position once everything settles down. That could take a while, but I think there’s clear potential here.
Brand power
Sometimes the power of a brand can be hard to quantify. But not with Reckitt – the strength of its names shows up in the company’s gross margin.
Reckitt vs. Unilever gross margins 2014-23
Created at TradingView
Over the last 10 years, the firm has consistently maintained gross margins in excess of 57%. That’s far higher than Unilever, whose best year resulted in just under 45% margins.
In fact, Reckitt stacks up pretty well against some of the best businesses in the world. Its margins over the last decade resemble those at Google’s parent company, Alphabet.
Reckitt vs. Alphabet gross margins 2014-23
Created at TradingView
That’s a sign there’s something really outstanding about the firm’s brand portfolio. It’s able to charge a significant markup on the products it makes because of the power behind the names.
Should investors buy, sell, or hold Reckitt shares?
I think Reckitt has a good business and this will emerge sooner or later. The question in the short term is whether the stock has further to fall before it does.
The stock market doesn’t like uncertainty and the company has a lot of that at the moment. But investors with a long-term outlook might well want to consider buying the shares right now.
The post As the Reckitt share price falls another 8%, what should investors do? appeared first on The Motley Fool UK.
Like buying £1 for 31p
This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!
Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.
What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?
See the full investment case
More reading
Will the Reckitt share price finally recover after announcing a major shakeup?
2 stunning FTSE dividend growth shares down 25% and 27% I’ll buy and hold forever
These FTSE 100 shares are undervalued by as much as 44%!
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Stephen Wright has positions in Unilever. The Motley Fool UK has recommended Alphabet, Reckitt Benckiser Group Plc, and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
